PTJ
PROK icon

Paul Tudor Jones’s ProKidney PROK Stock Holding History

Paul Tudor Jones’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-30,484
Closed -$75K – 3026
2024
Q2 		$75K Buy
+30,484
New +$81.8K ﹤0.01% 2214
2023
Q4 		– Sell
-30,727
Closed -$141K – 2791
2023
Q3 		$141K Buy
+30,727
New +$294K ﹤0.01% 2129
2023
Q2 		– Sell
-12,917
Closed -$146K – 2832
2023
Q1 		$146K Buy
+12,917
New +$137K ﹤0.01% 2220

Other funds holding PROK

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $112M AUM 3.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Paul Tudor Jones's PROK Position: Q3 2024 in Review

Paul Tudor Jones sold out of ProKidney (PROK) in Q3 2024, closing a stake of 30,484 shares — an estimated $75K sold.

Paul Tudor Jones first reported a position in PROK in Q1 2023 and held it in 3 quarters. The position peaked at $146K in Q1 2023. 71 funds tracked by Wall St. Rank hold PROK as of Q3 2024.

  • Paul Tudor Jones reported no remaining ProKidney position as of Q3 2024 after selling out during the quarter.
  • Paul Tudor Jones sold 30,484 ProKidney shares in Q3 2024, an estimated $75K.
  • Paul Tudor Jones first reported a position in ProKidney in Q1 2023 and held it in 3 quarters.
  • Paul Tudor Jones's ProKidney position peaked at $146K in Q1 2023.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q3 2024.

Based on Tudor Investment Corp's 13F filing for Q3 2024, filed 14 Nov 2024.